Sign in

CIK 0001427925

  • Non-accelerated filer
  • Smaller reporting company

TALPHERA, INC.

Sign in to watch
Ticker
TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412193603
Phone
+1 650-216-3500
Business address
1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
Former names
ACELRX PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-31 Hamel Lawrence G Chief Development Officer Grant or award +6,876 $1.49 $10K 24,371
2018-08-07 EDWARDS MARK G Director Purchase +5,300 $2.84 $15K 160,300
2018-08-07 Angotti Vincent J. Chief Executive Officer Purchase +10,000 $2.90 $29K 35,000
2018-08-06 Palmer Pamela P Chief Medical Officer Purchase +37,000 $2.75 $102K 456,134
2018-08-06 ASADORIAN RAFFI Chief Financial Officer Purchase +5,000 $2.75 $14K 32,000
2018-06-14 ADAMS ADRIAN Director Grant or award · Stock Options (Right to Buy) +15,000 15,000
2018-06-14 Afable Richard Director Grant or award · Stock Options (Right to Buy) +15,000 15,000
2018-06-14 HOFFMAN C STEVEN Director Grant or award · Stock Options (Right to Buy) +15,000 15,000
2018-06-14 EDWARDS MARK G Director Grant or award · Stock Options (Right to Buy) +15,000 15,000

Page 17 of 17 · 329 trades